Evidence map›Paper›PMID 34065887›Full record

ArticleInternational journal of molecular sciences2021

Sensitive High-Throughput Assays for Tumour Burden Reveal the Response of a

Jamie Adams, Andreu Casali, Kyra Campbell

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Medical science pulse · 2025
    Article
  5. Review
  6. Drosophila as a Model for Metastasis.Advances in experimental medicine and biology · 2025
    Review
  7. Growth deregulation and interaction with host hemocytes contribute to tumor progression in a Drosophila brain tumor model.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
  9. Fruit fly for anticancer drug discovery and repurposing.Annals of medicine and surgery (2012) · 2023
    Article
  10. Article
  11. Frontiers in genetics · 2022
    Review
  12. Frontiers in oncology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Jamie AdamsDepartment of Biomedical Science and Bateson Centre, The University of Sheffield, Sheffield S10 2TN, UK.
Andreu CasaliDepartament de Ciències Mèdiques Bàsiques, Universitat de Lleida and IRBLleida, 25198 Lleida, Spain.
Kyra CampbellDepartment of Biomedical Science and Bateson Centre, The University of Sheffield, Sheffield S10 2TN, UK.ORCID 0000-0001-8573-4756
University of Sheffield · GBUniversitat de Lleida · ES

Funding

Ministerio de Ciencia y Tecnología PID2019-1946GB-100Wellcome Trust 204615Wellcome Trust 204615/Z/16/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genes, ReporterAnimalsAnimals, Genetically ModifiedAntineoplastic AgentsColorectal NeoplasmsDrosophila melanogasterDrug Screening Assays, AntitumorFemaleFluorouracilGreen Fluorescent ProteinsHigh-Throughput Screening AssaysHumansLuciferasesOxaliplatinTumor BurdenXenograft Model Antitumor AssaysAntineoplastic AgentsFluorouracilGreen Fluorescent ProteinsLuciferasesOxaliplatincolorectal cancerDrosophiladrug screeninghigh-throughput

Identifiers

PMID34065887
PMCPMC8151205
OpenAlexW3161360153

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.